SECOND MESSENGERS AND PROTEIN PHOSPHORYLATION IN CAROTID CHEMOTRANSDUCTION

颈动脉化学转导中的第二信使和蛋白质磷酸化

基本信息

  • 批准号:
    6112017
  • 负责人:
  • 金额:
    $ 13.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-06-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

The carotid body, an arterial chemorecptor organ, possesses specialized preneural type I cells which contain an array of excitatory and inhibitory neurotransmitter agents. Current views suggest that chemostimuli initiate a complex cascade of primary transductive events in type I cells, which culminates in transmitter release and excitation of nearby chemosensory nerve endings. Type I cell activity is also modulated by neuroactive substances released from chemosensory nerve fibers. We showed previously that excitation and inhibition of type I cells is mediated by classical second messengers, including Ca 2+ and cyclic nuicleotides. The current application extends our studies of signal transduction to consider the role of protein kinases, phosphatases, and important target phosphoproteins. A multidisciplinary approach will investigate these cellular mechanisms, as formulated in the following three specfic aims: 1) The cellular machinery which mediates protein phosphorylation in the carotid body will be identified and localized using immunocytochemical techniques to study protein kinases, phosphoprotein phosphatases and important target phosphoproteins. In addition, gel electrophoretic techniques (SDS-PAGE) combined with 32 P-gamma-ATP labeling will be used charaterize changes in phosphorylation of diverse proteins in response to of chemoreceptor and second messenger stimuli, respectively. 2) Studies of the role of protein phosphorylation in synthesis and release of neurotransmitters from the carotid body will examine the effects of specific kinases and phosphatase inhibitors on catecholamine and nitric oxiden (N0) metabolism. The net physiological effects of altered transmitter release will be monitored as the chemoreceptor activity of the carotid sinus nerve. 3) The role of protein phosphorylation in modulation of type I cell membrane currents and intracellular ionic activities will be examined with patch- clamp and fluorescent dye cell-imaging techniques. These studies will focus on the regulation of potassium and calcium channels, as well as the cellular mechanisms underlying chemoreceptor inhibition mediated both by endogenous N0, and atrial natriuretic peptide (ANP).
颈动脉体是一种动脉化学感受器

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SALVATORE J FIDONE其他文献

SALVATORE J FIDONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SALVATORE J FIDONE', 18)}}的其他基金

Neuro-immune mechanisms in carotid body chemoreceptor response to chronic hypoxia
颈动脉体化学感受器对慢性缺氧反应的神经免疫机制
  • 批准号:
    7580345
  • 财政年份:
    2008
  • 资助金额:
    $ 13.49万
  • 项目类别:
Neuro-immune mechanisms in carotid body chemoreceptor response to chronic hypoxia
颈动脉体化学感受器对慢性缺氧反应的神经免疫机制
  • 批准号:
    7746439
  • 财政年份:
    2008
  • 资助金额:
    $ 13.49万
  • 项目类别:
Neuro-immune mechanisms in carotid body chemoreceptor response to chronic hypoxia
颈动脉体化学感受器对慢性缺氧反应的神经免疫机制
  • 批准号:
    8197205
  • 财政年份:
    2008
  • 资助金额:
    $ 13.49万
  • 项目类别:
SECOND MESSENGERS AND PROTEIN PHOSPHORYLATION IN CAROTID CHEMOTRANSDUCTION
颈动脉化学转导中的第二信使和蛋白质磷酸化
  • 批准号:
    6273606
  • 财政年份:
    1998
  • 资助金额:
    $ 13.49万
  • 项目类别:
CHRONIC HYPOXIA EFFECTS ON CAROTID CHEMORECEPTION
慢性缺氧对颈动脉化学感受的影响
  • 批准号:
    2891560
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:
CHRONIC HYPOXIA EFFECTS ON CAROTID CHEMORECEPTION
慢性缺氧对颈动脉化学感受的影响
  • 批准号:
    6393285
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:
MODULATION OF CHEMICAL TRANSMISSION IN SENSORY RECEPTORS
感觉受体中化学传递的调节
  • 批准号:
    2262459
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:
CHEMICAL TRANSMISSION IN SENSORY RECEPTORS
感觉受体中的化学物质传递
  • 批准号:
    3394924
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:
CHEMICAL TRANSMISSION IN SENSORY RECEPTORS
感觉受体中的化学物质传递
  • 批准号:
    3394926
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:
CHEMICAL AND IONIC MECHANISMS IN SENSORY TRANSDUCTION
感觉传导中的化学和离子机制
  • 批准号:
    3099298
  • 财政年份:
    1978
  • 资助金额:
    $ 13.49万
  • 项目类别:

相似海外基金

Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
  • 批准号:
    10627996
  • 财政年份:
    2022
  • 资助金额:
    $ 13.49万
  • 项目类别:
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
  • 批准号:
    10419574
  • 财政年份:
    2022
  • 资助金额:
    $ 13.49万
  • 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
  • 批准号:
    10676800
  • 财政年份:
    2020
  • 资助金额:
    $ 13.49万
  • 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
  • 批准号:
    10442162
  • 财政年份:
    2020
  • 资助金额:
    $ 13.49万
  • 项目类别:
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity Supplement
盐敏感性高血压多样性补充剂中心房钠尿肽的线粒体介导作用和治疗潜力
  • 批准号:
    10337412
  • 财政年份:
    2020
  • 资助金额:
    $ 13.49万
  • 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
  • 批准号:
    10472035
  • 财政年份:
    2020
  • 资助金额:
    $ 13.49万
  • 项目类别:
Development of a high-precision diagnostic method for heart failure utilizing abnormal biosynthesis of beta-atrial natriuretic peptide in the failing heart
利用衰竭心脏中β-心房钠尿肽的异常生物合成开发心力衰竭的高精度诊断方法
  • 批准号:
    20K08414
  • 财政年份:
    2020
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide induces peroxisome proliferator
心钠素诱导过氧化物酶体增殖
  • 批准号:
    15K10206
  • 财政年份:
    2015
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
心房钠尿肽可防止癌症通过血管内皮细胞转移。
  • 批准号:
    26461393
  • 财政年份:
    2014
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel strategy for heart failure treatment with recombinant atrial natriuretic peptide-induced cardiac progenitor cells
重组心钠素诱导的心脏祖细胞治疗心力衰竭的新策略
  • 批准号:
    25461069
  • 财政年份:
    2013
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了